• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞特异性造影剂:并非那么简单。

Hepatocyte-specific contrast media: not so simple.

作者信息

Trout Andrew T, Towbin Alexander J, Smith Ethan A, Gupta Anita, Dillman Jonathan R

机构信息

Department of Radiology, MLC 5031, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH, 45229-3026, USA.

Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

出版信息

Pediatr Radiol. 2018 Aug;48(9):1245-1255. doi: 10.1007/s00247-018-4108-x. Epub 2018 Aug 4.

DOI:10.1007/s00247-018-4108-x
PMID:30078050
Abstract

Hepatocyte-specific contrast media are gadolinium chelates that are taken up by hepatocytes and partially cleared via the biliary tree. The absence of lesional uptake of the contrast media in the hepatobiliary phase is a marker of either the absence of hepatocytes or of poorly functioning, neoplastic hepatocytes. Uptake of the contrast media in the hepatobiliary phase, whether equal to or greater than background liver, reflects the presence of hepatocytes but does not equate to absence of neoplasia. Accurate diagnosis of liver lesions utilizing hepatocyte-specific contrast media requires an understanding of the mechanisms of uptake and clearance of the contrast media to avoid misdiagnosis. In this review we discuss the mechanisms of hepatocellular transport of hepatocyte-specific contrast media and utilize an understanding of those mechanisms to discuss the imaging appearance of a subset of hepatocellular lesions that can be seen in the pediatric and young adult liver. We pay particular attention to lesions that appear iso- to hyperintense in the hepatobiliary phase but have the potential for adverse clinical outcomes. We also discuss strategies for identifying these lesions.

摘要

肝细胞特异性造影剂是钆螯合物,可被肝细胞摄取并通过胆管系统部分清除。在肝胆期造影剂在病变部位无摄取是肝细胞缺失或肿瘤性肝细胞功能不良的标志。在肝胆期造影剂的摄取,无论等于或大于肝脏背景,都反映了肝细胞的存在,但并不等同于无肿瘤形成。利用肝细胞特异性造影剂准确诊断肝脏病变需要了解造影剂的摄取和清除机制,以避免误诊。在本综述中,我们讨论了肝细胞特异性造影剂的肝细胞转运机制,并利用对这些机制的理解来讨论在儿童和年轻成人肝脏中可见的一部分肝细胞病变的影像学表现。我们特别关注在肝胆期表现为等密度至高信号但具有不良临床结局可能性的病变。我们还讨论了识别这些病变的策略。

相似文献

1
Hepatocyte-specific contrast media: not so simple.肝细胞特异性造影剂:并非那么简单。
Pediatr Radiol. 2018 Aug;48(9):1245-1255. doi: 10.1007/s00247-018-4108-x. Epub 2018 Aug 4.
2
MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.使用肝脏特异性对比剂进行肝细胞期成像时炎症性肝细胞腺瘤的MRI特征
J Magn Reson Imaging. 2014 May;39(5):1259-64. doi: 10.1002/jmri.24281. Epub 2013 Jul 29.
3
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.肝细胞特异性造影剂在肝胆磁共振成像中的作用。
Semin Ultrasound CT MR. 2013 Feb;34(1):44-53. doi: 10.1053/j.sult.2012.11.004.
4
Practical use and pitfalls of hepatocyte-specific contrast agents (HSCAs) for pediatric hepatic and biliary magnetic resonance imaging.用于儿科肝脏和胆道磁共振成像的肝细胞特异性对比剂(HSCAs)的实际应用和陷阱。
Abdom Radiol (NY). 2017 Feb;42(2):502-520. doi: 10.1007/s00261-016-0916-3.
5
Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.在钆塞酸增强肝胆期 MRI 上见到的肝脏高信号病变的鉴别诊断。
AJR Am J Roentgenol. 2011 Jul;197(1):W44-52. doi: 10.2214/AJR.10.5845.
6
Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?肝细胞癌在肝脏磁共振成像中与各种类似病变的鉴别:使用肝细胞特异性对比剂时有哪些要点?
World J Gastroenterol. 2016 Jan 7;22(1):284-99. doi: 10.3748/wjg.v22.i1.284.
7
Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.钆塞酸二钠增强肝胆期成像上的高信号病灶。
AJR Am J Roentgenol. 2012 Nov;199(5):W575-86. doi: 10.2214/AJR.11.8205.
8
[Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].[钆塞酸二钠增强磁共振成像:局灶性结节性增生与肝细胞腺瘤的鉴别诊断]
Acta Med Port. 2011 Dec;24 Suppl 2:531-8. Epub 2011 Dec 31.
9
Magnetic resonance imaging features of common focal liver lesions in children.儿童常见肝脏局灶性病变的磁共振成像特征
Pediatr Radiol. 2018 Aug;48(9):1234-1244. doi: 10.1007/s00247-018-4218-5. Epub 2018 Aug 4.
10
Hepatocyte-specific magnetic resonance imaging contrast agents.肝细胞特异性磁共振成像造影剂。
Hepatology. 2011 Feb;53(2):678-82. doi: 10.1002/hep.24158.

引用本文的文献

1
Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies.儿童恶性肿瘤治疗后肝脏病变的超声造影表现
Cancer Imaging. 2024 Aug 29;24(1):115. doi: 10.1186/s40644-024-00750-3.
2
Fontan-associated liver disease: Diagnosis, surveillance, and management.Fontan相关肝病:诊断、监测与管理
Front Pediatr. 2023 Mar 3;11:1100514. doi: 10.3389/fped.2023.1100514. eCollection 2023.
3
Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

本文引用的文献

1
Diagnostic Value of Gd-EOB-DTPA-MRI for Hepatocellular Adenoma: A Meta-Analysis.钆塞酸二钠增强磁共振成像对肝细胞腺瘤的诊断价值:一项Meta分析
J Cancer. 2017 May 11;8(7):1301-1310. doi: 10.7150/jca.17778. eCollection 2017.
2
Hepatocellular adenoma: Classification, variants and clinical relevance.肝细胞腺瘤:分类、变异型及临床相关性。
Semin Diagn Pathol. 2017 Mar;34(2):112-125. doi: 10.1053/j.semdp.2016.12.007. Epub 2016 Dec 20.
3
Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background.
评估肝细胞癌的局部区域治疗反应:肝胆对比剂与细胞外对比剂的比较。
Abdom Radiol (NY). 2021 Aug;46(8):3565-3578. doi: 10.1007/s00261-021-03076-x. Epub 2021 Apr 15.
4
Robotic resection of liver focal nodal hyperplasia guided by indocyanine green fluorescence imaging: A preliminary analysis of 23 cases.吲哚菁绿荧光成像引导下肝脏局灶性结节性增生的机器人切除术:23例初步分析
World J Gastrointest Oncol. 2020 Dec 15;12(12):1407-1415. doi: 10.4251/wjgo.v12.i12.1407.
5
Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.儿童先天性门体分流:关联、并发症及结局
Dig Dis Sci. 2020 Apr;65(4):1239-1251. doi: 10.1007/s10620-019-05834-w. Epub 2019 Sep 23.
6
Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.儿童患者对比增强肝脏磁共振成像用静脉内钆基肝细胞特异性对比剂(HSCAs):放射科医生应该了解的内容。
Pediatr Radiol. 2019 Sep;49(10):1256-1268. doi: 10.1007/s00247-019-04476-4. Epub 2019 Jul 26.
良性肝细胞结节:基于分子背景的钆塞酸二钠增强磁共振成像肝胆期表现
Radiographics. 2016 Nov-Dec;36(7):2010-2027. doi: 10.1148/rg.2016160037. Epub 2016 Oct 14.
4
Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.基于其独特的分子机制,钆塞酸二钠在功能磁共振成像中的应用。
Br J Radiol. 2016;89(1058):20150666. doi: 10.1259/bjr.20150666. Epub 2015 Dec 23.
5
Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.局灶性结节性增生和肝细胞腺瘤:钆塞酸增强磁共振成像的准确性——系统评价。
Radiology. 2015 Nov;277(2):413-23. doi: 10.1148/radiol.2015142986. Epub 2015 May 26.
6
Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging.钆塞酸增强磁共振成像在肝细胞腺瘤中的形态学和分子特征。
Radiology. 2015 Oct;277(1):104-13. doi: 10.1148/radiol.2015142366. Epub 2015 May 18.
7
Hepatobiliary agents and their role in LI-RADS.肝胆药物及其在肝脏影像报告和数据系统(LI-RADS)中的作用。
Abdom Imaging. 2015 Mar;40(3):613-25. doi: 10.1007/s00261-014-0227-5.
8
The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion.已知或疑似肝脏病变患者从婴儿期到青年期的肝细胞期成像的影响。
Pediatr Radiol. 2015 Mar;45(3):354-65. doi: 10.1007/s00247-014-3160-4. Epub 2014 Sep 23.
9
Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.炎症性肝细胞腺瘤在钆塞酸增强磁共振成像(MRI)上可模仿局灶性结节性增生。
AJR Am J Roentgenol. 2014 Oct;203(4):W408-14. doi: 10.2214/AJR.13.12251. Epub 2014 Jul 23.
10
Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.钆布醇-葡甲胺增强磁共振成像用于儿童肝脏病变
Pediatr Radiol. 2014 Oct;44(10):1266-74. doi: 10.1007/s00247-014-2975-3. Epub 2014 Apr 27.